整合身体成分指标用于头颈癌放射治疗的预后评估:进展与临床意义

Integrating Body Composition Metrics for Prognostication in Head and Neck Cancer Radiotherapy: Advances and Clinical Implications

Recent evidence highlights the prognostic significance of body composition metrics, including BMI, skeletal muscle mass, and adiposity distribution, in head and neck cancer radiotherapy outcomes. Automated 3D CT phenotyping refines risk stratification to guide individualized supportive care.
腹膜细胞学阳性或局限性腹膜转移胃癌的治疗策略优化

Optimizing Treatment Strategies for Gastric Cancer with Positive Peritoneal Cytology or Localized Peritoneal Metastasis

This article reviews a multicenter study comparing outcomes of different treatment approaches for gastric cancer patients with positive peritoneal cytology (CY1) and/or localized peritoneal metastasis (P1a), highlighting the superior survival with upfront chemotherapy followed by gastrectomy after cytology conversion.
射频消融治疗钙化性乳头状甲状腺微小癌:长期疗效与钙化演变

Long-Term Outcomes and Calcification Dynamics After Radiofrequency Ablation of Calcified Papillary Thyroid Microcarcinomas

This retrospective study demonstrates that radiofrequency ablation (RFA) effectively treats low-risk papillary thyroid microcarcinomas (PTMC), including those with intratumoral calcifications, with excellent technical success, significant tumor volume reduction, and minimal complications over long-term follow-up.
Orforglipron 在 2 型糖尿病中的心血管安全性和治疗潜力:来自 ACHIEVE-4 3 期试验的发现

Cardiovascular Safety and Therapeutic Potential of Orforglipron Versus Insulin Glargine in Type 2 Diabetes with Elevated Cardiovascular Risk: Insights from the ACHIEVE-4 Phase 3 Trial

A comprehensive review of the ACHIEVE-4 trial confirms orforglipron's cardiovascular safety non-inferior to insulin glargine in type 2 diabetes patients at elevated cardiovascular risk, highlighting its oral administration and safety profile advantages.